The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors
Clinical trial NCT00002213 · COMPLETED
Trial details
- NCT number
- NCT00002213
- Sponsor
- Glaxo Wellcome
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.